Bioactor and Ferrer HealthTech sign Collaboration Agreement
date:Jan 22, 2014
ellent solution for long-term prevention.Bioactoris addressing this need by developing a unique product for endothelial health cordiart. Cordiartstimulates the eNOS-enzyme which plays a pivotal role in the synthesis of Nitric Oxide, one of the most important regulators of vascular elasticity.

BioActor, based in Maastricht, Netherlands, is a product development company that supplies proprietary bioactive formulations to the nutrition healthcare industry. The company focuses on the development
5/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/27 11:38